Cardiovascular biomarkers in patients with psoriasis

Experimental Dermatology

Volumn 23, Issue 5, 2014, Pages 322-325

  Gerdes, Sascha ^a   Osadtschy, Swetlana ^b   Buhles, Norbert ^b   Baurecht, Hansjoerg ^a   Mrowietz, Ulrich ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Asklepios Nordseeklinik ^*  (Germany)

Author keywords

Cardiovascular disease; Fetuin A; MGP; Psoriasis; sCD40L

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; FETUIN A; OSTEOCALCIN; OXIDIZED LOW DENSITY LIPOPROTEIN; BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; MATRIX GLA PROTEIN; SCLEROPROTEIN;

ARTICLE; BODY MASS; CARDIOVASCULAR INFLAMMATION; CONTROLLED STUDY; DISEASE SEVERITY; ELISA KIT; HUMAN; MAJOR CLINICAL STUDY; PSORIASIS AREA AND SEVERITY INDEX; PSORIATIC ARTHRITIS; VASCULAR DISEASE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ADULT; BLOOD; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; COHORT ANALYSIS; COMPLICATION; FEMALE; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; NORMAL HUMAN; PSORIASIS;

ADULT; ALPHA-2-HS-GLYCOPROTEIN; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CALCIUM-BINDING PROTEINS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CD40 LIGAND; COHORT STUDIES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PSORIASIS;

EID: 84899525200     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12381     Document Type: Article

References (30)

1. Reich K, Kruger K, Mossner R et al. Br J Dermatol 2009: 160: 1040-1047.
2. Gelfand J M, Troxel A B, Lewis J D et al. Arch Dermatol 2007: 143: 1493-1499.
3. Mallbris L, Akre O, Granath F et al. Eur J Epidemiol 2004: 19: 225-230.
4. Gupta Y, Moller S, Zillikens D et al. Exp Dermatol 2013: 22: 552-553.
5. Lu Y, Chen H, Nikamo P et al. J Invest Dermatol 2013: 133: 836-839.
6. Boehncke W H, Boehncke S, Tobin A M et al. Exp Dermatol 2011: 20: 303-307.
7. Pamukcu B, Lip G Y, Snezhitskiy V et al. Ann Med 2011: 43: 331-340.
8. Mitra S, Goyal T, Mehta J L. Cardiovasc Drugs Ther 2011: 25: 419-429.
9. Yousuf O, Mohanty B D, Martin S S et al. J Am Coll Cardiol 2013: 62: 397-408.
10. Sage A P, Tintut Y, Demer L L. Nat Rev Cardiol 2010: 7: 528-536.
11. Gerdes S, Osadtschy S, Rostami-Yazdi M et al. Exp Dermatol 2012: 21: 43-47.
12. Dowlatshahi E A, van der Voort E A, Arends L R et al. Br J Dermatol 2013: 169: 266-282.
13. Beygi S, Lajevardi V, Abedini R. J Eur Acad Dermatol Venereol 2013. doi:10.1111/jdv.12257 [Epub ahead of print].
14. Shanahan C M. Circulation 2007: 116: 2782-2785.
15. Rezg R, Barreto F C, Barreto D V et al. J Nephrol 2011: 24: 416-427.
16. Aikawa E, Nahrendorf M, Figueiredo J L et al. Circulation 2007: 116: 2841-2850.
17. Hermans M M, Brandenburg V, Ketteler M et al. Kidney Int 2007: 72: 202-207.
18. Ketteler M, Bongartz P, Westenfeld R et al. Lancet 2003: 361: 827-833.
19. Mori K, Emoto M, Inaba M. Recent Pat Endocr Metab Immune Drug Discov 2011: 5: 124-146.
20. Jung C H, Kim B Y, Kim C H et al. Diab Vasc Dis Res 2013: 10: 459-467.
21. Singh M, Sharma P K, Garg V K et al. J Pharm Pharmacol 2012: 64: 1703-1708.
22. Antoniades C, Bakogiannis C, Tousoulis D et al. J Am Coll Cardiol 2009: 54: 669-677.
23. Hassan G S, Merhi Y, Mourad W. Immunobiology 2012: 217: 521-532.
24. Mysliwiec H, Flisiak I, Baran A et al. Folia Histochem Cytobiol 2012: 50: 75-79.
25. Pamuk G E, Nuri P O, Orum H et al. Platelets 2009: 20: 493-497.
26. Pamuk G E, Vural O, Turgut B et al. Platelets 2008: 19: 146-154.
27. Zervou M I, Goulielmos G N, Castro-Giner F et al. Hum Immunol 2011: 72: 761-765.
28. Li D, Liu L, Chen H et al. Arterioscler Thromb Vasc Biol 2003: 23: 816-821.
29. Profumo E, Di Franco M, Buttari B et al. Mediators Inflamm 2012: 2012: 503942.
30. Tekin N S, Tekin I O, Barut F et al. Mediators Inflamm 2007: 2007: 78454.